Literature DB >> 6754363

Phthalate esters as peroxisome proliferator carcinogens.

J R Warren, N D Lalwani, J K Reddy.   

Abstract

The phthalate ester di(2-ethylhexyl) phthalate is both a peroxisome proliferator and a hepatic carcinogen. Peroxisome proliferators as a class are hepatocarcinogenic in rodent species. However, none of the peroxisome proliferators tested to date including the phthalate esters and related alcohol and acid analogs have demonstrated mutagenic or DNA-damaging activity in the in vitro Salmonella typhimurium/microsomal or the lymphocyte 3H-thymidine assays. A working hypothesis is proposed that peroxisome proliferation itself initiates neoplastic transformation of hepatic parenchymal cells by increasing intracellular rates of DNA-damaging reactive oxygen production. Evidence which supports such a hypothesis includes increased fatty acid beta-oxidation, elevated H2O2 levels, accumulation of peroxidized lipofuscin, disproportionately small increase in catalase, and elevated peroxisomal uricase activity which accompany peroxisome proliferation in hepatocytes. Direct testing of this hypothesis will provide insight into mechanisms of phthalate ester carcinogenicity and cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6754363      PMCID: PMC1569007          DOI: 10.1289/ehp.824535

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  34 in total

1.  Di-(2-ethylhexyl)phthalate: an industrial plasticizer induces hypolipidemia and enhances hepatic catalase and carnitine acetyltransferase activities in rat and mice.

Authors:  J K Reddy; D E Moody; D L Azarnoff; M S Rao
Journal:  Life Sci       Date:  1976-05-01       Impact factor: 5.037

2.  Chain scission of ribonucleic acid and deoxyribonucleic acid by ionizing radiation and hydrogen peroxide in vitro and in Escherichia coli cells.

Authors:  E C Pollard; P K Weller
Journal:  Radiat Res       Date:  1967-11       Impact factor: 2.841

3.  The kinetics of degradation of DNA and RNA by H 2 O 2 .

Authors:  H R Massie; H V Samis; M B Baird
Journal:  Biochim Biophys Acta       Date:  1972-07-31

4.  Hepatocellular carcinomas in acatalasemic mice treated with nafenopin, a hypolipidemic peroxisome proliferator.

Authors:  J K Reddy; S Rao; D E Moody
Journal:  Cancer Res       Date:  1976-04       Impact factor: 12.701

5.  Delivery of di-2-ethylhexyl phthalate to patients during hemodialysis.

Authors:  T P Gibson; W A Briggs; B J Boone
Journal:  J Lab Clin Med       Date:  1976-03

6.  Rat liver peroxisomes catalyze the beta oxidation of fatty acids.

Authors:  P B Lazarow
Journal:  J Biol Chem       Date:  1978-03-10       Impact factor: 5.157

7.  Three hypolipidemic drugs increase hepatic palmitoyl-coenzyme A oxidation in the rat.

Authors:  P B Lazarow
Journal:  Science       Date:  1977-08-05       Impact factor: 47.728

8.  A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug.

Authors:  P B Lazarow; C De Duve
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

9.  Morphometric analysis of the ultrastructural changes in rat liver induced by the peroxisome proliferator SaH 42-348.

Authors:  D E Moody; J K Reddy
Journal:  J Cell Biol       Date:  1976-12       Impact factor: 10.539

10.  Response of hepatic microbodies to a hypolipidemic agent, ethyl chlorophenoxyisobutyrate (CPIB).

Authors:  D J Svoboda; D L Azarnoff
Journal:  J Cell Biol       Date:  1966-08       Impact factor: 10.539

View more
  17 in total

Review 1.  PVC as pharmaceutical packaging material. A literature survey with special emphasis on plasticized PVC bags.

Authors:  A A Van Dooren
Journal:  Pharm Weekbl Sci       Date:  1991-06-21

2.  Fragile TIM-4-expressing tissue resident macrophages are migratory and immunoregulatory.

Authors:  Thomas B Thornley; Zemin Fang; Savithri Balasubramanian; Rafael A Larocca; Weihua Gong; Shipra Gupta; Eva Csizmadia; Nicolas Degauque; Beom Seok Kim; Maria Koulmanda; Vijay K Kuchroo; Terry B Strom
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

3.  Quantitative analysis of the early changes of hepatocyte nuclei after treating Syrian golden hamsters with di(2-ethylhexyl)phthalate.

Authors:  D Komitowski; P Schmezer; B Schmitt; V Ehemann; S Muto
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

4.  Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases.

Authors:  K R Stephenson; S M Steinberg; K S Hughes; J T Vetto; P H Sugarbaker; A E Chang
Journal:  Ann Surg       Date:  1988-12       Impact factor: 12.969

5.  Modeling di (2-ethylhexyl) Phthalate (DEHP) and Its Metabolism in a Body's Organs and Tissues through Different Intake Pathways into Human Body.

Authors:  Ao Li; Lingyi Kang; Runjie Li; Sijing Wu; Ke Liu; Xinke Wang
Journal:  Int J Environ Res Public Health       Date:  2022-05-09       Impact factor: 4.614

6.  Alteration of hepatic phospholipids in rats and mice by feeding di-(2-ethylhexyl)adipate and di-(2-ethylhexyl)phthalate.

Authors:  T Yanagita; M Satoh; H Nomura; N Enomoto; M Sugano
Journal:  Lipids       Date:  1987-08       Impact factor: 1.880

7.  Di(2-ethylhexyl)adipate (DEHA): effect on plasma lipids and hepatic cholesterolgenesis in the rat.

Authors:  F P Bell
Journal:  Bull Environ Contam Toxicol       Date:  1984-01       Impact factor: 2.151

Review 8.  Endocrine disrupters as obesogens.

Authors:  Felix Grün; Bruce Blumberg
Journal:  Mol Cell Endocrinol       Date:  2009-03-09       Impact factor: 4.102

9.  Plasticizer extraction of Taxol infusion solution from various infusion devices.

Authors:  B Mass; C Huber; I Krämer
Journal:  Pharm World Sci       Date:  1996-04

10.  Effects of the PPARα Agonist and Widely Used Antihyperlipidemic Drug Gemfibrozil on Hepatic Toxicity and Lipid Metabolism.

Authors:  Michael L Cunningham; Bradley J Collins; Milton R Hejtmancik; Ronald A Herbert; Gregory S Travlos; Molly K Vallant; Matthew D Stout
Journal:  PPAR Res       Date:  2010-10-04       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.